<DOC>
	<DOC>NCT00555204</DOC>
	<brief_summary>The purpose of this study is to test if the investigational medication ABT-089 is a safe and effective treatment for Alzheimer's disease.</brief_summary>
	<brief_title>Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cholinesterase Inhibitors</mesh_term>
	<criteria>Patient has mild to moderate Alzheimer's disease Patient has been receiving a stable dose of an acetylcholinesterase inhibitor Patient has a MMSE score between 12 and 26 Patient has a MHIS score of less than or equal to 4 Females must be postmenopausal for at least two years or surgically sterile Patient has an identified, reliable, caregiver who will support him/her to ensure compliance with treatment and will accompany them to each outpatient visit Patient is living in a nursing home Patient has a history of any significant neurologic disease other than Alzheimer's disease Patient has any uncontrolled medical illness Patient uses nonprescribed drugs of abuse or has a history of drug or alcohol abuse/dependence</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>mild to moderate Alzheimer's disease, memory, cognition, dementia</keyword>
</DOC>